Talphera (TLPH) Stock: Buy, Sell, or Hold?
TLPH - Talphera, Inc. Common Stock
$1.13
0.01 (0.89%)
▲
5d:
-4.24%
30d:
-5.83%
90d:
-4.24%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When TLPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TLPH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TLPH shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: TLPH is currently trading at $1.13, which is considered oversold relative to its 30-day fair value range of $1.16 to $1.22.
Technical Outlook: Technically, TLPH is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.21.
Market Sentiment: TLPH scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.12 (+176.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TLPH is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.21.
Market Sentiment: TLPH scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.12 (+176.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.16 -
$1.22
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 176.5% below Wall St target ($3.12)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.16 -
$1.22
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.21
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.06
Wall Street Target
$3.13
(+176.5%)
Share & Embed Analysis
Last updated: October 04, 2026 12:31 AM ET
Data refreshes hourly during market hours. Next update: 1:31 AM
Data refreshes hourly during market hours. Next update: 1:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 56 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 47 HOLD |
